Literature DB >> 12638716

Amplification-based nucleic acid scanning techniques to assess genetic polymorphism in Candida.

R S Dassanayake1, L P Samaranayake.   

Abstract

Opportunistic pathogen Candida causes common fungal infections that manifest both superficially and systemically, especially in compromised patients. Although C. albicans is by far the main etiological agent of candidosis, the frequency of isolation of other non-albicans species such as C. glabrata and C. krusei is increasing at an alarming rate. Therefore, the epidemiology, pathogenicity, and diagnosis of infections due to these organisms are of great importance. Of a variety of genotyping methods utilized for strain delineation of these Candida species, amplification-based techniques such as randomly amplified polymorphic DNA (RAPD), amplified fragment length polymorphism (AFLP), restriction digestion-mediated PCR (RFLP-PCR), and single-stranded conformational polymorphism (SSCP) and microsatellite PCR (interrepeat PCR, IR-PCR) are the most popular and widely used. In the last decade or so these techniques have helped unravel the clinical epidemiological features of pathogenicity, diversity, microevolution, and natural heterozygosity in Candida species. Here we review in detail the basic principles of RAPD, the nature of the primer and factors influencing its selection, and the limitations of RAPD assays as well as analysis and interpretation of banding profiles generated using the software programs. In addition, the principles of other RAPD-based amplification techniques (AFLP, RFLP-PCR, SSCP, and IR-PCR) and their application in molecular epidemiologic studies of Candida species in particular and other fungi in general are also reviewed. It is concluded that these methods have wide applicability in genotyping fungi, although they differ greatly in their resolution and have advantages and drawbacks depending on the task in question.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638716     DOI: 10.1080/713610402

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  7 in total

1.  Molecular typing of Candida albicans strains isolated from denture wearers by repetitive sequence-based PCR.

Authors:  O Abaci; A Haliki-Uztan; B Ozturk; S Toksavul; M Ulusoy; H Boyacioglu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-29       Impact factor: 3.267

2.  Molecular analysis of Candida glabrata clinical isolates.

Authors:  Norbert Berila; Julius Subik
Journal:  Mycopathologia       Date:  2010-03-17       Impact factor: 2.574

3.  Investigation of extracellular phospholipase and proteinase activities of Candida species isolated from individuals denture wearers and genotypic distribution of Candida albicans strains.

Authors:  Ozlem Abaci
Journal:  Curr Microbiol       Date:  2011-01-08       Impact factor: 2.188

4.  Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern.

Authors:  A Chakrabarti; M R Shivaprakash; I Curfs-Breuker; A Baghela; C H Klaassen; J F Meis
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

5.  High oral prevalence of Candida krusei in leprosy patients in northern Thailand.

Authors:  P A Reichart; L P Samaranayake; Y H Samaranayake; M Grote; E Pow; B Cheung
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  Genetic relatedness of subgingival and buccal Candida dubliniensis isolates in immunocompetent subjects assessed by RAPD-PCR.

Authors:  Virginia Marta Jewtuchowicz; Maria Teresa Mujica; Maria Celina Malzone; Alicia Cuesta; Maria Lorena Nastri; Cristina Adela Iovannitti; Alcira Cristina Rosa
Journal:  J Oral Microbiol       Date:  2009-10-15       Impact factor: 5.474

7.  Molecular typing of Candida albicans isolates from hospitalized patients.

Authors:  Patrícia de Souza Bonfim-Mendonça; Adriana Fiorini; Cristiane Suemi Shinobu-Mesquita; Lilian Cristiane Baeza; Maria Aparecida Fernandez; Terezinha Inez Estivalet Svidzinski
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.